MODERNA ($MRNA) posted quarterly earnings results for Q1 2026 on Friday, May 1st. The company reported earnings of -$1.18 per share, beating estimates of -$3.32 by $2.14. The company also reported revenue of $389,000,000, beating estimates of $232,527,992 by $156,472,008.
You can see Quiver Quantitative's $MRNA stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
MODERNA Insider Trading Activity
MODERNA insiders have traded $MRNA stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $MRNA stock by insiders over the last 6 months:
- STEPHEN HOGE (President) sold 160,009 shares for an estimated $7,814,839
- SHANNON THYME KLINGER (Chief Legal Officer) sold 13,885 shares for an estimated $726,046
- NOUBAR AFEYAN sold 23,853 shares for an estimated $703,305
- ABBAS HUSSAIN sold 504 shares for an estimated $13,910
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
MODERNA Hedge Fund Activity
We have seen 298 institutional investors add shares of MODERNA stock to their portfolio, and 321 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 15,741,014 shares (+127.9%) to their portfolio in Q4 2025, for an estimated $464,202,502
- CAPITAL WORLD INVESTORS added 12,828,040 shares (+inf%) to their portfolio in Q4 2025, for an estimated $378,298,899
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 6,254,709 shares (-79.7%) from their portfolio in Q4 2025, for an estimated $184,451,368
- ALYESKA INVESTMENT GROUP, L.P. added 3,228,531 shares (+inf%) to their portfolio in Q4 2025, for an estimated $95,209,379
- BNP PARIBAS FINANCIAL MARKETS added 3,058,933 shares (+279.7%) to their portfolio in Q4 2025, for an estimated $90,207,934
- BLACKROCK, INC. added 2,977,816 shares (+10.1%) to their portfolio in Q4 2025, for an estimated $87,815,793
- CITADEL ADVISORS LLC removed 1,408,601 shares (-70.9%) from their portfolio in Q4 2025, for an estimated $41,539,643
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
MODERNA Analyst Ratings
Wall Street analysts have issued reports on $MRNA in the last several months. We have seen 1 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 02/23/2026
- Leerink Partners issued a "Underperform" rating on 11/21/2025
- B of A Securities issued a "Underperform" rating on 11/10/2025
To track analyst ratings and price targets for MODERNA, check out Quiver Quantitative's $MRNA forecast page.
MODERNA Price Targets
Multiple analysts have issued price targets for $MRNA recently. We have seen 11 analysts offer price targets for $MRNA in the last 6 months, with a median target of $30.0.
Here are some recent targets:
- Eliana Merle from Barclays set a target price of $48.0 on 04/02/2026
- Edward Tenthoff from Piper Sandler set a target price of $69.0 on 02/23/2026
- Cory Kasimov from Evercore ISI Group set a target price of $35.0 on 02/17/2026
- Salveen Richter from Goldman Sachs set a target price of $41.0 on 02/17/2026
- Luca Issi from RBC Capital set a target price of $30.0 on 02/17/2026
- Eliana Merle from UBS set a target price of $34.0 on 01/07/2026
- Andrew Tsai from Jefferies set a target price of $30.0 on 12/12/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
